Cite
Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week
MLA
Martin Daumer, et al. “Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 89, no. 2, Oct. 2021, pp. 191–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e8d822287e947e4275e511e6e9962a10&authtype=sso&custid=ns315887.
APA
Martin Daumer, Wendy Ankrom, Deanne Jackson Rudd, Yang Liu, Dirk Schürmann, Jörg Hofmann, Marian Iwamoto, Inge De Lepeleire, Christian Keicher, Evan J. Friedman, Martine Robberechts, Andrea K. Schaeffer, S. Aubrey Stoch, Jay A. Grobler, Bhargava Kandala, & Saijuan Zhang. (2021). Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week. Journal of Acquired Immune Deficiency Syndromes (1999), 89(2), 191–198.
Chicago
Martin Daumer, Wendy Ankrom, Deanne Jackson Rudd, Yang Liu, Dirk Schürmann, Jörg Hofmann, Marian Iwamoto, et al. 2021. “Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week.” Journal of Acquired Immune Deficiency Syndromes (1999) 89 (2): 191–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e8d822287e947e4275e511e6e9962a10&authtype=sso&custid=ns315887.